d Selecting a characterizing subset of features based on mRMR for classification.
Langerhans cells (LC) represent a well characterized subset of dendritic cells located in the epidermis of skin and mucosae.
Furthermore, a poorly characterized subset of cells isolated from human hair follicles has been shown to express Oct4 and to display multipotent behavior in vitro [ 11].
Previously characterized subsets of Treg cells and naive and effector CD4+ T cells were purified using FACS sorting based on expression of CD25 and CD45RO (>97 99% purity).
In conclusion, we have characterized subsets of miRNAs that are regulated by c-Myc and are important in ES cell identity.
CONCLUSIONS: Immunohistochemistry is a useful adjunct in characterizing subsets of paediatric medulloblastomas and confirms that larger co-operative studies may be fruitful in identifying a prognostic utility of a combined histochemical/immunohistochemical analysis on these tumours.
In recent years, an increasing number of reports have used multi-omics technologies to characterize subsets of bone biological molecular networks.
To compare the differentiation of early B- and T-lymphoid precursors, we have used immune adherence combined with analytical flow cytometric techniques to enrich and characterize subsets of the small population of bone marrow mononuclear cells that express the enzyme terminal deoxynucleotidyl transferase (TdT) but lack the CD19 B-lymphoid marker.
Fusions defining subtypes within a cancer include RET and NTRK gene fusions in subsets of papillary thyroid carcinoma [ 121], while PAX8-PPARγ fusions characterize subsets of follicular thyroid carcinoma [ 22, 122].
In addition we characterized a subset of de novo enhancers, which are enriched for MYC binding at their epicenter, suggesting a modulatory function in their activation.
For the serial prime∶boost immunogenicity analysis that was the focus of this study, we characterized a subset of the previously described epitope-scaffolds, namely ES1, ES2, ES4 and ES5 (see Fig 1 for schematic fusion protein models and graft sequences).
